Clinical outcomes and risk factors of hepatopulmonary syndrome in children

Kwang Yeon Kim, Tae Hyeong Kim, Jeong Moo Lee, Nam Joon Yi, Hyun Young Kim, Jin Soo Moon, Jae Sung Ko

Research output: Contribution to journalArticlepeer-review


Hepatopulmonary syndrome (HPS) is defined as three distinct features: liver disease, hypoxemia, and intrapulmonary vasodilation. The purpose of this study was to investigate the clinical outcomes of pediatric HPS and to identify the risk factors for HPS in children with biliary atresia (BA). We performed a retrospective cohort study of all children who were diagnosed with HPS between 2000 and 2018 at Seoul National University Hospital. The clinical features and outcomes of the 10 patients diagnosed with HPS were reviewed. To clarify the risk factors of HPS in patients with BA, we reviewed 120 patients diagnosed with BA. Underlying liver disease was BA in 8 patients, portal vein agenesis in 1 patient, and portal vein thrombosis in 1 patient. A total of 7 patients underwent liver transplantation (LT). Currently, all seven patients, including 3 patients with severe HPS, survived after LT. The prevalence of HPS in children with BA was 7%. Polysplenia/interrupted inferior vena was the only risk factor for HPS in BA patients in multivariate analysis. The Pediatric End-Stage Liver Disease score was not associated with the development of HPS. Children with severe HPS undergoing LT had excellent outcomes. Screening for HPS in children with BA is required regardless of the severity of liver diseases.

Original languageEnglish
Article number4134
JournalScientific Reports
Issue number1
StatePublished - Dec 2021

Fingerprint Dive into the research topics of 'Clinical outcomes and risk factors of hepatopulmonary syndrome in children'. Together they form a unique fingerprint.

Cite this